首页> 美国卫生研究院文献>Scientific Reports >MicroRNA profiling and identification of let-7a as a target to prevent chemotherapy-induced primordial follicles apoptosis in mouse ovaries
【2h】

MicroRNA profiling and identification of let-7a as a target to prevent chemotherapy-induced primordial follicles apoptosis in mouse ovaries

机译:MicroRNA谱分析和let-7a的鉴定以防止化疗诱导的小鼠卵巢原始卵泡凋亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cancer treatments as cyclophosphamide and its active metabolites are highly gonadotoxic leading to follicle apoptosis and depletion. Considering the risk of subsequent infertility, fertility preservation is recommended. Beside the germ cells and gametes cryopreservation options, ovarian pharmacological protection during treatment appears to be very attractive. Meanwhile, the advances in the field of oncology have brought microRNAs into spotlight as a potential feature of cancer treatment. Herein, we investigated miRNAs expressions in response to chemotherapy using postnatal-day-3 (PND3) mouse ovaries. Our results revealed that several miRNAs are differently expressed during chemotherapy exposure. Amongst them, let-7a was the most profoundly downregulated and targets genes involved in crucial cellular processes including apoptosis. Thus we developed a liposome-based system to deliver the let-7a mimic in whole PND3 ovaries in vitro. We showed that let-7a mimic prevented the upregulation of genes involved in cell death and reduced the chemotherapy-induced ovarian apoptosis, suggesting that it can be an interesting target to preserve ovarian function. However, its impact on subsequent follicular development has to be further elucidated in vivo using an appropriate delivery system. In this study, we demonstrated that miRNA replacement approaches can be a useful tool to reduce chemotherapy-induced ovarian damage in the future.
机译:作为环磷酰胺及其活性代谢物的癌症治疗具有高度的性腺毒性,导致卵泡凋亡和耗竭。考虑到随后发生不孕症的风险,建议保留生育力。除了生殖细胞和配子的冷冻保存方法外,治疗期间的卵巢药理保护似乎非常有吸引力。同时,肿瘤学领域的进展使microRNA成为癌症治疗的潜在特征而备受关注。在本文中,我们调查了使用出生后第3天(PND3)小鼠卵巢对化疗反应的miRNA表达。我们的结果表明,在化疗过程中几种miRNA的表达不同。其中,let-7a被最深刻地下调,并靶向与重要细胞过程(包括凋亡)有关的基因。因此,我们开发了一种基于脂质体的系统,可在体外将Let-7a模拟物传递到整个PND3卵巢中。我们表明,let-7a模拟物可阻止涉及细胞死亡的基因上调,并减少化疗诱导的卵巢细胞凋亡,这表明它可能是保留卵巢功能的有趣靶标。然而,必须使用适当的递送系统在体内进一步阐明其对随后卵泡发育的影响。在这项研究中,我们证明了miRNA替代方法可以成为将来减少化疗引起的卵巢损害的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号